相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Risk of Melanoma With Phosphodiesterase Type 5 Inhibitor Use Among Patients With Erectile Dysfunction, Pulmonary Hypertension, and Lower Urinary Tract Symptoms
Eugene Shkolyar et al.
JOURNAL OF SEXUAL MEDICINE (2018)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2018)
Impact of use of phosphodiesterase type 5 inhibitors (PDE5-I) after radical prostatectomy (RP) on biochemical recurrence-free (BCRF) and overall survival (OS): A retrospective study from the Northwestern University SPORE in prostate cancer.
Arden B. Roston et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Phosphodiesterase type 5 and cancers: progress and challenges
Ines Barone et al.
ONCOTARGET (2017)
Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome
Valeriana Cesarini et al.
ONCOTARGET (2017)
Relation of phosphodiesterase type 5 inhibitors and malignant melanoma: a meta-analysis and systematic review
Jie Wang et al.
ONCOTARGET (2017)
Erectile function recovery in men treated with phosphodiesterase type 5 inhibitor administration after bilateral nerve-sparing radical prostatectomy: a systematic review of placebo-controlled randomized trials with trial sequential analysis
E. Limoncin et al.
ANDROLOGY (2017)
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Definition of Grading Patterns and Proposal for a New Grading System
Jonathan I. Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
A Detailed Analysis of the Association Between Postoperative Phosphodiesterase Type 5 Inhibitor Use and the Risk of Biochemical Recurrence After Radical Prostatectomy
Andrea Gallina et al.
EUROPEAN UROLOGY (2015)
Upregulation of Phosphodiesterase type 5 in the Hyperplastic Prostate
Wenhao Zhang et al.
SCIENTIFIC REPORTS (2015)
Effects of Tadalafil Treatment on Erectile Function Recovery Following Bilateral Nerve-sparing Radical Prostatectomy: A Randomised Placebo-controlled Study (REACTT)
Francesco Montorsi et al.
EUROPEAN UROLOGY (2014)
Tadalafil for Prevention of Erectile Dysfunction After Radiotherapy for Prostate Cancer The Radiation Therapy Oncology Group [0831] Randomized Clinical Trial
Thomas M. Pisansky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Sildenafil Use and Increased Risk of Incident Melanoma in US Men A Prospective Cohort Study
Wen-Qing Li et al.
JAMA INTERNAL MEDICINE (2014)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2013)
Phosphodiesterase Type 5 Inhibition Reverts Prostate Fibroblast-to-Myofibroblast Trans-Differentiation
Christoph Zenzmaier et al.
ENDOCRINOLOGY (2012)
Prevention and Management of Postprostatectomy Sexual Dysfunctions Part 2: Recovery and Preservation of Erectile Function, Sexual Desire, and Orgasmic Function
Andrea Salonia et al.
EUROPEAN UROLOGY (2012)
Monotherapy with Tadalafil or Tamsulosin Similarly Improved Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in an International, Randomised, Parallel, Placebo-Controlled Clinical Trial
Matthias Oelke et al.
EUROPEAN UROLOGY (2012)
Tadalafil 2.5 or 5 mg Administered Once Daily for 12 Weeks in Men with Both Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia: Results of a Randomized, Placebo-Controlled, Double-Blind Study
Russell Blair Egerdie et al.
JOURNAL OF SEXUAL MEDICINE (2012)
Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1-year, open-label extension study
Craig F. Donatucci et al.
BJU INTERNATIONAL (2011)
Emerging concepts in erectile preservation following radical prostatectomy: a guide for clinicians
D. J. Moskovic et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2011)
Is Radical Prostatectomy the Gold Standard for Localized Prostate Cancer?
William M. Mendenhall et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2010)
Attenuated Proliferation and Trans-Differentiation of Prostatic Stromal Cells Indicate Suitability of Phosphodiesterase Type 5 Inhibitors for Prevention and Treatment of Benign Prostatic Hyperplasia
Christoph Zenzmaier et al.
ENDOCRINOLOGY (2010)
Characterization of Phosphodiesterase Type 5 Expression and Functional Activity in the Human Male Lower Urinary Tract
Benedetta Fibbi et al.
JOURNAL OF SEXUAL MEDICINE (2010)
The ENDOTRIAL Study: A Spontaneous, Open-Label, Randomized, Multicenter, Crossover Study on the Efficacy of Sildenafil, Tadalafil, and Vardenafil in the Treatment of Erectile Dysfunction
Emmanuele A. Jannini et al.
JOURNAL OF SEXUAL MEDICINE (2009)
Effect of Nightly versus On-Demand Vardenafil on Recovery of Erectile Function in Men Following Bilateral Nerve-Sparing Radical Prostatectomy
Francesco Montorsi et al.
EUROPEAN UROLOGY (2008)
Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate
S Ückert et al.
EUROPEAN UROLOGY (2006)
Subcellular localization and regulation of type-1C and type-5 phosphodiesterases
S Dolci et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Pathophysiology and rehabilitation of erectile dysfunction after nerve-sparing prostatectomy
C van der Horst et al.
UROLOGE A (2005)
Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy
G Brock et al.
JOURNAL OF UROLOGY (2003)
Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up
R Raina et al.
UROLOGY (2003)
Lead times and overdetection due to prostate-specific antigen screening:: Estimates from the European randomized study of screening for prostate cancer
G Draisma et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Effect of sildenafil citrate on post-radical prostatectomy erectile dysfunction
MI Feng et al.
JOURNAL OF UROLOGY (2000)
Efficacy of sildenafil in erectile dysfunction after radical prostatectomy
DS Blander et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2000)
Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions
SH Soderling et al.
CURRENT OPINION IN CELL BIOLOGY (2000)
Expression of three isoforms of cGMP-binding cGMP-specific phosphodiesterase (PDES) in human penile cavernosum
CS Lin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Role of Viagra after radical prostatectomy
CD Zippe et al.
UROLOGY (2000)
分享论文
